arrow
J

Jonathan S. Nguyen-Van-Tam

nottingham university hospital nhs trust
H指数:65
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology
2025-01-011
PRE
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

molnupiravir在高危成人门诊患者中SARS-CoV-2病毒和抗体反应的随机对照试验

2024-02-2310
OAAI
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial

莫那比拉韦对高危社区新型冠状病毒肺炎成人的成本效用分析: 全景试验的经济评估

2024-01-162
OAAI
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
LANCET
IF88.5
2023-01-01237
OAAI
Comparison of UK paediatric SARS-CoV-2 admissions across the first and second pandemic waves

第一次和第二次大流行波中英国儿科SARS-CoV-2入院的比较

2022-04-2210
OAAI
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
2022-03-31293
OA
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

使用ISARIC WHO临床表征方案对新型冠状病毒肺炎住院的成年人的4C预后模型进行前瞻性验证

THORAX
IF7.7
2021-11-2224
OAAI
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study

成人新型冠状病毒肺炎疫苗接种后新型冠状病毒肺炎相关死亡和住院风险预测: 全国前瞻性队列研究

2021-09-17234
OAAI
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
2021-07-0180
OAAI